Sante Health Ventures III Overview
Sante Health Ventures III General Information
Description
Sante Health Ventures III is an early-stage venture capital fund managed by Santé Ventures. The fund is located in Austin, Texas.
Contact Information
Fund Manager's Location
- 1300 Red River Street
- Suite 1500
- Austin, TX 78701
- United States
Sante Health Ventures III Investments (23)
Sante Health Ventures III has made a total of 23 investments. Its most recent deal was a with Geneos Therapeutics for . The deal was made on 10-Mar-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Geneos Therapeutics | 10-Mar-2026 | Drug Discovery | Generating Revenue | |||
| Endovascular Engineering | 14-Feb-2025 | Surgical Devices | Generating Revenue | |||
| KelaHealth | 29-Jul-2022 | Decision/Risk Analysis | Generating Revenue | |||
| Endovascular Engineering | 02-Apr-2022 | Surgical Devices | Pre-Clinical Trials | |||
| CardiacBooster | 01-Apr-2022 | Therapeutic Devices | Pre-Clinical Trials | |||
| Geneos Therapeutics | 21-Mar-2022 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Cryosa | 23-Sep-2021 | Therapeutic Devices | Clinical Trials - Phase 1 | |||
| RapidPulse | 23-Jun-2021 | Therapeutic Devices | Clinical Trials - General | |||
| Endogenex | 20-Apr-2021 | Early Stage VC (Series A2) | Therapeutic Devices | Startup | ||
| Iterion Therapeutics | 16-Feb-2021 | Later Stage VC (Series B1) | Drug Discovery | Clinical Trials - Phase 2 |
Sante Health Ventures III Investment Strategy
Sante Health Ventures III Limited Partners (3)
Sentara Healthcare is one of Sante Health Ventures III’s 3 limited partners. Its latest Original was on 29-May-2019.
| Limited Partner Name | Type | Status | Commitment | Date | Commitment Type |
|---|---|---|---|---|---|
| Sentara Healthcare | Current | 29-May-2019 | Original | ||
| The William K. Warren Foundation | Current | 29-May-2019 | Original | ||
| Pennsylvania Public School Employees Retirement System | Public Pension Fund | Current | 22-Jan-2019 | Original |
Sante Health Ventures III Returns Data
The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.
Sante Health Ventures III Returns History
| Period | Contribution (by all LPs) | Dry Powder | Distribution (to all LPs) | NAV | Total Fund Distr+NAV | IRR | DPI | RVPI | TVPI | Dry Powder % |
|---|
Sante Health Ventures III Benchmark (74)
| Fund Name | Fund Type | Vintage | IRR | Quartile | As of Date |
|---|---|---|---|---|---|
| Sequoia Capital U.S. Growth Fund VIII | 30-Jun-2025 | ||||
| Arch Venture Fund IX Overage | 30-Jun-2026 | ||||
| ARCH Venture Fund X Overage | 30-Jun-2026 | ||||
| Norwest Venture Partners XIV | |||||
| Sequoia Capital Global Growth Fund III | 30-Jun-2026 | ||||
| Emergence Capital Partners V | |||||
| Bellus Ventures II | |||||
| Versant Venture Capital VII | 31-Dec-2025 | ||||
| Foundry Group Next 2018 | 30-Jun-2026 | ||||
| General Catalyst Group IX | 30-Jun-2026 |
Sante Health Ventures III FAQs
-
What is Sante Health Ventures III?
Sante Health Ventures III is an early-stage venture capital fund managed by Santé Ventures.
-
Who manages Sante Health Ventures III?
Sante Health Ventures III is managed by Santé Ventures.
-
Where is Sante Health Ventures III domiciled?
Sante Health Ventures III is domiciled in United States: Delaware.
-
What is Sante Health Ventures III's size?
Sante Health Ventures III has a size of .
-
What type of fund is Sante Health Ventures III?
The fund type of Sante Health Ventures III is Venture.
-
What is the status of Sante Health Ventures III?
Sante Health Ventures III is closed.
-
What has Sante Health Ventures III invested in?
Sante Health Ventures III has made numerous investments in companies like Geneos Therapeutics, Endovascular Engineering, and KelaHealth within the Drug Discovery, Surgical Devices, and Decision/Risk Analysis industries.
-
What has Sante Health Ventures III invested in recently?
Sante Health Ventures III's latest investment was on 10-Mar-2026 in Geneos Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process